DOI:
10.1055/s-00000134
Diabetologie und Stoffwechsel
LinksClose Window
References
Bergenstal RM, Wysham C, Macconell L et al.
Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial.
Lancet 2010;
376 (9739) 431-439
DOI: 10.1016/S0140-6736(10)60590-9.
http://www.ncbi.nlm.nih.gov/pubmed/20580422
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.